Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF729 NCOA2 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ADNP PRDM5 ZNF25 ZNF529 MEIS2 MEIS3P1 ZNF441 SIX6 THAP11 ZNF28 NEUROD2 ZNF644 ZNF846 SKOR1 SMARCA4 ZNF799 ATF4 ZBED1 USP3 ZNF443 HDAC1 ZNF121 MYBL2	5.93e-08	1459	154	32	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF729 ZNF384 ZNF573 ZNF337 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 ZNF25 ZNF529 MEIS2 MEIS3P1 ZNF441 SIX6 THAP11 ZNF28 NEUROD2 ZNF644 ZNF846 SKOR1 ZNF799 ATF4 ZBED1 ZNF443 ZNF121 MYBL2	3.36e-06	1412	154	28	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF729 NCOA2 ZNF384 ZNF573 ZNF366 ZNF423 ZBTB9 ZNF521 PRDM5 MEIS2 MEIS3P1 SIX6 THAP11 ZNF28 NEUROD2 ZNF644 SKOR1 SMARCA4 ATF4 ZBED1 USP3 HDAC1 ZNF121 MYBL2	2.91e-05	1244	154	24	GO:0000978
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	RASA1 ARHGAP15 RASA3 DENND11 RGS12 DENND3 ASAP1 PLEKHG1 EGF TBC1D1 FARP1 DOCK7 FGD5 ARHGEF4	3.96e-05	507	154	14	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	RASA1 ARHGAP15 RASA3 DENND11 RGS12 DENND3 ASAP1 PLEKHG1 EGF TBC1D1 FARP1 DOCK7 FGD5 ARHGEF4	3.96e-05	507	154	14	GO:0030695
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF729 NCOA2 ZNF384 ZNF573 ZNF366 ZNF423 ZBTB9 ZNF521 PRDM5 MEIS2 MEIS3P1 SIX6 THAP11 ZNF28 NEUROD2 ZNF644 SKOR1 SMARCA4 ATF4 ZBED1 USP3 HDAC1 ZNF121 MYBL2	4.10e-05	1271	154	24	GO:0000987
GeneOntologyMolecularFunction	SUMO transferase activity	KIAA1586 TOPORS ZBED1 TRIM60	1.65e-04	36	154	4	GO:0019789
GeneOntologyMolecularFunction	low-affinity IgG receptor activity	FCGR3A FCGR3B	3.51e-04	4	154	2	GO:0019772
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DENND11 DENND3 PLEKHG1 EGF FARP1 DOCK7 FGD5 ARHGEF4	4.36e-04	231	154	8	GO:0005085
GeneOntologyMolecularFunction	SUMO ligase activity	KIAA1586 ZBED1 TRIM60	4.66e-04	20	154	3	GO:0061665
GeneOntologyMolecularFunction	IgE receptor activity	FCGR3A FCGR3B	8.69e-04	6	154	2	GO:0019767
GeneOntologyMolecularFunction	MAP kinase kinase kinase kinase activity	MAP4K3 MAP4K5	8.69e-04	6	154	2	GO:0008349
GeneOntologyMolecularFunction	IgE binding	FCGR3A FCGR3B	1.21e-03	7	154	2	GO:0019863
GeneOntologyMolecularFunction	IgG receptor activity	FCGR3A FCGR3B	1.21e-03	7	154	2	GO:0019770
GeneOntologyBiologicalProcess	eye development	SPRED2 PDGFRA FAT3 ZHX2 MEIS2 MEIS3P1 SIX6 KMT2C SMARCA4 IFT122 ATF4 NIPBL SDK1 HDAC1	1.05e-05	480	149	14	GO:0001654
GeneOntologyBiologicalProcess	head development	POMT2 MYH3 FUT10 FAT4 PDGFRA ZNF423 ZSWIM6 ZNF365 MEIS2 MEIS3P1 PALS1 BLOC1S6 NEUROD2 LDB1 EGF DOCK7 SMARCA4 NIPBL PCDH9 HDAC1	1.05e-05	919	149	20	GO:0060322
GeneOntologyBiologicalProcess	visual system development	SPRED2 PDGFRA FAT3 ZHX2 MEIS2 MEIS3P1 SIX6 KMT2C SMARCA4 IFT122 ATF4 NIPBL SDK1 HDAC1	1.12e-05	483	149	14	GO:0150063
GeneOntologyBiologicalProcess	sensory system development	SPRED2 PDGFRA FAT3 ZHX2 MEIS2 MEIS3P1 SIX6 KMT2C SMARCA4 IFT122 ATF4 NIPBL SDK1 HDAC1	1.35e-05	491	149	14	GO:0048880
GeneOntologyBiologicalProcess	brain development	POMT2 FUT10 FAT4 ZNF423 ZSWIM6 ZNF365 MEIS2 MEIS3P1 PALS1 BLOC1S6 NEUROD2 LDB1 EGF DOCK7 SMARCA4 NIPBL PCDH9 HDAC1	4.94e-05	859	149	18	GO:0007420
GeneOntologyBiologicalProcess	perforin production	FCGR3A FCGR3B	5.18e-05	2	149	2	GO:0035944
GeneOntologyBiologicalProcess	sensory organ development	FAT4 SPRED2 PDGFRA FAT3 ZHX2 MEIS2 MEIS3P1 SIX6 KMT2C NEUROD2 SMARCA4 IFT122 ATF4 NIPBL SDK1 HDAC1	7.91e-05	730	149	16	GO:0007423
Domain	zf-C2H2	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 CHAMP1 ZNF25 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	1.89e-07	693	151	21	PF00096
Domain	Znf_C2H2-like	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 CHAMP1 ZNF25 ZNF365 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	4.52e-07	796	151	22	IPR015880
Domain	Znf_C2H2	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 CHAMP1 ZNF25 ZNF365 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	5.46e-07	805	151	22	IPR007087
Domain	ZnF_C2H2	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 CHAMP1 ZNF25 ZNF365 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	5.81e-07	808	151	22	SM00355
Domain	Znf_C2H2/integrase_DNA-bd	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ADNP PRDM5 CHAMP1 ZNF25 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	8.34e-07	694	151	20	IPR013087
Domain	ZINC_FINGER_C2H2_2	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 CHAMP1 ZNF25 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	1.17e-06	775	151	21	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 ADNP PRDM5 CHAMP1 ZNF25 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	1.21e-06	777	151	21	PS00028
Domain	-	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 PRDM5 CHAMP1 ZNF25 ZNF529 ZNF441 ZNF28 ZNF644 ZNF846 ZNF799 ZNF443 ZNF121	2.47e-06	679	151	19	3.30.160.60
Domain	zf-C2H2_6	ZNF729 ZNF384 ZNF573 ZNF366 ZNF423 ZNF521 PRDM5 ZNF25 ZNF846 ZNF799 ZNF443 ZNF121	9.64e-06	314	151	12	PF13912
Domain	PH	RASA1 ARHGAP15 RASA3 CNKSR2 ASAP1 PLEKHG1 FARP1 PLEKHA5 FGD5 ARHGEF4	1.75e-05	229	151	10	PF00169
Domain	-	SPRED2 RASA1 ARHGAP15 RASA3 CNKSR2 RGS12 ASAP1 PLEKHG1 TBC1D1 FARP1 PLEKHA5 FGD5 ARHGEF4	1.80e-05	391	151	13	2.30.29.30
Domain	PH_dom-like	SPRED2 RASA1 ARHGAP15 RASA3 CNKSR2 RGS12 ASAP1 PLEKHG1 TBC1D1 FARP1 PLEKHA5 FGD5 ARHGEF4	4.37e-05	426	151	13	IPR011993
Domain	ALIX_LYPXL_bnd	PDCD6IP PTPN23	6.49e-05	2	151	2	PF13949
Domain	Cyt_c_oxidase_suVIIB	COX7B COX7B2	6.49e-05	2	151	2	IPR008433
Domain	-	COX7B COX7B2	6.49e-05	2	151	2	4.10.51.10
Domain	Cyt_c_oxidase_suVIIB_dom	COX7B COX7B2	6.49e-05	2	151	2	IPR023272
Domain	ALIX_V_dom	PDCD6IP PTPN23	6.49e-05	2	151	2	IPR025304
Domain	COX7B	COX7B COX7B2	6.49e-05	2	151	2	PF05392
Domain	Twinfilin	TWF2 TWF1	6.49e-05	2	151	2	IPR028458
Domain	PH	RASA1 ARHGAP15 RASA3 CNKSR2 ASAP1 PLEKHG1 FARP1 PLEKHA5 FGD5 ARHGEF4	9.01e-05	278	151	10	SM00233
Domain	PH_DOMAIN	RASA1 ARHGAP15 RASA3 CNKSR2 ASAP1 PLEKHG1 FARP1 PLEKHA5 FGD5 ARHGEF4	9.28e-05	279	151	10	PS50003
Domain	PH_domain	RASA1 ARHGAP15 RASA3 CNKSR2 ASAP1 PLEKHG1 FARP1 PLEKHA5 FGD5 ARHGEF4	9.56e-05	280	151	10	IPR001849
Domain	DUF21	CNNM2 CNNM3	3.85e-04	4	151	2	IPR002550
Domain	MAPKKKK	MAP4K3 MAP4K5	3.85e-04	4	151	2	IPR021160
Domain	DUF21	CNNM2 CNNM3	3.85e-04	4	151	2	PF01595
Domain	TPR-like_helical_dom	APPBP2 COPE IFIT3 AAR2 NAA25 STIP1 IFT122 CABIN1	6.26e-04	233	151	8	IPR011990
Domain	BRO1	PDCD6IP PTPN23	6.39e-04	5	151	2	PF03097
Domain	BRO1_dom	PDCD6IP PTPN23	6.39e-04	5	151	2	IPR004328
Domain	BRO1	PDCD6IP PTPN23	6.39e-04	5	151	2	SM01041
Domain	BRO1	PDCD6IP PTPN23	6.39e-04	5	151	2	PS51180
Domain	-	PDCD6IP PTPN23	6.39e-04	5	151	2	1.25.40.280
Domain	KRAB	ZNF729 ZNF573 ZNF337 ZNF25 ZNF529 ZNF441 ZNF28 ZNF846 ZNF799 ZNF443	6.78e-04	358	151	10	PS50805
Domain	KRAB	ZNF729 ZNF573 ZNF337 ZNF25 ZNF529 ZNF441 ZNF28 ZNF846 ZNF799 ZNF443	6.78e-04	358	151	10	PF01352
Domain	KRAB	ZNF729 ZNF573 ZNF337 ZNF25 ZNF529 ZNF441 ZNF28 ZNF846 ZNF799 ZNF443	8.54e-04	369	151	10	SM00349
Domain	KRAB	ZNF729 ZNF573 ZNF337 ZNF25 ZNF529 ZNF441 ZNF28 ZNF846 ZNF799 ZNF443	8.72e-04	370	151	10	IPR001909
Domain	C-RASSF	RASSF6 RASSF1	9.53e-04	6	151	2	IPR033614
Domain	Nore1-SARAH	RASSF6 RASSF1	9.53e-04	6	151	2	PF16517
Domain	TPR-contain_dom	APPBP2 PTPN23 IFIT3 NAA25 STIP1 CABIN1	1.39e-03	150	151	6	IPR013026
Domain	-	APPBP2 COPE IFIT3 NAA25 STIP1 IFT122 CABIN1	1.49e-03	207	151	7	1.25.40.10
Domain	Helicase_C	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	1.77e-03	107	151	5	PF00271
Domain	HELICc	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	1.77e-03	107	151	5	SM00490
Domain	Helicase_C	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	1.85e-03	108	151	5	IPR001650
Domain	C1	KMT2C RASSF1 PRKCB PRKCH	1.90e-03	65	151	4	SM00109
Domain	HELICASE_CTER	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	1.92e-03	109	151	5	PS51194
Domain	HELICASE_ATP_BIND_1	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	1.92e-03	109	151	5	PS51192
Domain	DEXDc	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	1.92e-03	109	151	5	SM00487
Domain	Helicase_ATP-bd	CHD1 SMARCA4 DDX20 DDX21 SNRNP200	2.00e-03	110	151	5	IPR014001
Domain	PE/DAG-bd	KMT2C RASSF1 PRKCB PRKCH	2.01e-03	66	151	4	IPR002219
Domain	RhoGEF	PLEKHG1 FARP1 FGD5 ARHGEF4	2.24e-03	68	151	4	SM00325
Domain	SARAH	RASSF6 RASSF1	2.25e-03	9	151	2	PS50951
Domain	SARAH_dom	RASSF6 RASSF1	2.25e-03	9	151	2	IPR011524
Domain	TPR_REGION	APPBP2 PTPN23 IFIT3 NAA25 STIP1 CABIN1	2.25e-03	165	151	6	PS50293
Domain	TPR	APPBP2 PTPN23 IFIT3 NAA25 STIP1 CABIN1	2.25e-03	165	151	6	PS50005
Domain	RhoGEF	PLEKHG1 FARP1 FGD5 ARHGEF4	2.49e-03	70	151	4	PF00621
Domain	DH_2	PLEKHG1 FARP1 FGD5 ARHGEF4	2.49e-03	70	151	4	PS50010
Domain	-	PLEKHG1 FARP1 FGD5 ARHGEF4	2.62e-03	71	151	4	1.20.900.10
Domain	DH-domain	PLEKHG1 FARP1 FGD5 ARHGEF4	2.62e-03	71	151	4	IPR000219
Domain	ADF	TWF2 TWF1	2.80e-03	10	151	2	SM00102
Domain	Cofilin_ADF	TWF2 TWF1	2.80e-03	10	151	2	PF00241
Domain	ADF_H	TWF2 TWF1	2.80e-03	10	151	2	PS51263
Domain	ADF-H	TWF2 TWF1	2.80e-03	10	151	2	IPR002108
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 PDCD6IP ANK3 BCLAF1 CNKSR2 ADNP TWF1 PALS1 CSNK1A1L MDN1 LDB1 FARP1 KIAA1217 DOCK7 SMARCA4 SMARCC1 PRKCB PLEKHA5 STIP1 CABIN1 NIPBL	1.97e-09	963	154	21	28671696
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 ANK3 BCLAF1 PTPN23 TWF2 ADNP CHAMP1 KMT2C PALS1 DOCK7 SMARCA4 SMARCC1 PLEKHA5 SNRNP200 HDAC1	2.56e-08	549	154	15	38280479
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ZNF384 FAM120B PDCD6IP RASA3 MAP4K3 WDR70 PTPN23 CHD1 RHOT2 COLGALT1 ADNP ASAP1 AAR2 MDN1 MAP4K5 SMARCA4 SMARCC1 PLEKHA5 DDX20 DDX21 USP3 SNRNP200 NIPBL	3.32e-08	1353	154	23	29467282
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	APPBP2 ZNF423 CNKSR2 ZSWIM6 ZHX2 DENND11 ZNF365 ASAP1 PLEKHG1 TBC1D1 ZNF644 DOCK7 ARHGEF4	3.76e-08	407	154	13	12693553
Pubmed	A human MAP kinase interactome.	PDCD6IP ANK3 MAP4K3 PTPN23 NCKAP5 ASAP1 KMT2C BLOC1S6 MAP4K5 PLEKHA5 PRKCH ATF4 ARHGEF4 SNRNP200	3.99e-08	486	154	14	20936779
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 ZNF423 ZBTB9 ZNF521 ZHX2 KMT2C LDB1 ZNF644 SMARCA4 SMARCC1 NIPBL HDAC1	6.15e-08	351	154	12	38297188
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	ZBTB9 CHD1 ADNP CHAMP1 MDN1 ZNF644 SMARCA4 NIPBL NOL8 MYBL2	6.32e-08	222	154	10	37071664
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	ZBTB9 ADNP CHAMP1 KMT2C SMARCA4 SMARCC1 CABIN1 HDAC1 MYBL2	6.38e-08	167	154	9	20362541
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF384 WDR70 ZBTB9 CHD1 ADNP CHAMP1 RAD51AP1 ZNF644 SMARCA4 SMARCC1 CABIN1 USP3 NIPBL HDAC1 MYBL2	9.65e-08	608	154	15	36089195
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ANK3 BCLAF1 COPE CHD1 HMMR COLGALT1 MRPS22 AAR2 PLEKHG1 CNNM3 MDN1 DNAJC28 MAP4K5 FARP1 ZNF644 DNAJC5G PDIA5 PLEKHA5 STIP1 IFT122 DDX21 SNRNP200 NOL8	1.80e-07	1487	154	23	33957083
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 FUT10 TRPC4AP PDCD6IP ANK3 RASA1 RASA3 WDR70 ZSWIM6 ZHX2 KMT2C LDB1 SMPDL3B TBC1D1 FARP1 KIAA1217 TLL1 PDIA5 CAMKMT TRMT13 IFT122 ARHGEF4 USP3	1.85e-07	1489	154	23	28611215
Pubmed	The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKCtheta: a possible molecular basis for myoblast diversification during limb histogenesis.	MYH2 MYH3 PRKCB PRKCH	2.56e-07	13	154	4	8948582
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FAM120B PDCD6IP BCLAF1 ZNF423 COPE ZNF521 ADNP CHAMP1 MRPS22 THAP11 FARP1 DOCK7 SMARCA4 SMARCC1 PDIA5 DDX21 SNRNP200 NIPBL FKBP3	3.56e-07	1082	154	19	38697112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 ZNF384 ARHGAP15 BCLAF1 ZBTB9 TWF2 HMMR ADNP THAP11 KMT2C ZNF644 SMARCA4 SMARCC1 SNRNP200 NIPBL FKBP3 HDAC1 ZNF121 MYBL2	4.76e-07	1103	154	19	34189442
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FAT4 CNNM2 FAT3 RHOT2 CNNM3 PCDH9	5.46e-07	67	154	6	21875946
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH2 MYH3 MAP4K3 BCLAF1 DUSP9 CHD1 RHOT2 HMMR ADNP DENND11 CSNK1A1L EGF RASSF6 MAP4K5 RASSF1 PDIA5 HDAC1	6.62e-07	910	154	17	36736316
Pubmed	Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.	NCOA2 SMARCA4 SMARCC1	8.46e-07	5	154	3	14966121
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ZBTB9 RHOT2 ZHX2 CHAMP1 PTGS2 MDN1 SMARCC1 INTS9 DDX20 TOPORS CABIN1 USP3	9.32e-07	453	154	12	29656893
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TRPC4AP PDCD6IP LYPLAL1 BCLAF1 COPE HMMR CHAMP1 MRPS22 AAR2 THAP11 CSNK1A1L RASSF1 ZNF644 SMARCA4 SMARCC1 DDX21 SNRNP200 NIPBL MYBL2	9.45e-07	1155	154	19	20360068
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZNF384 NEBL BCLAF1 WDR70 PTPN23 CHD1 ADNP CHAMP1 TWF1 KIAA1217 SMARCA4 STIP1 DDX21 SNRNP200 NIPBL FKBP3 NOL8	9.46e-07	934	154	17	33916271
Pubmed	Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells.	ZNF384 ADNP CHAMP1 CSNK1A1L SMARCA4 SMARCC1 CABIN1 HDAC1	1.39e-06	178	154	8	27637333
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FAM120B PDCD6IP ANK3 MAP4K3 BCLAF1 TWF2 CNKSR2 PTGS2 MRPS22 ASAP1 TWF1 CSNK1A1L FARP1 KIAA1217 DOCK7 SMARCA4 PRKCB PLEKHA5 STIP1 ARHGEF4 SNRNP200	1.51e-06	1431	154	21	37142655
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	ZNF384 CHD1 CHAMP1 LDB1 SMARCA4 SMARCC1 DDX21 HDAC1	1.71e-06	183	154	8	36129980
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 ZNF384 ADNP SMARCA4 SMARCC1 NIPBL	1.95e-06	83	154	6	28794006
Pubmed	Chromatin remodeling complex interacts with ADD1/SREBP1c to mediate insulin-dependent regulation of gene expression.	SMARCA4 SMARCC1 HDAC1	2.94e-06	7	154	3	17074803
Pubmed	CHD1 associates with NCoR and histone deacetylase as well as with RNA splicing proteins.	BCLAF1 CHD1 HDAC1	2.94e-06	7	154	3	12890497
Pubmed	Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex.	NCOA2 SMARCA4 SMARCC1	2.94e-06	7	154	3	9590696
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NCOA2 ZNF521 CHAMP1 ZNF25 MEIS2 SIX6 KMT2C ST6GAL2 NEUROD2 LDB1 SMARCA4 SMARCC1 ATF4 MYBL2	3.60e-06	709	154	14	22988430
Pubmed	Human transcription factor protein interaction networks.	NCOA2 COPE ZBTB9 ZNF521 RHOT2 ZHX2 ADNP MRPS22 THAP11 KMT2C PALS1 LDB1 ZNF644 SMARCA4 SMARCC1 STIP1 CABIN1 NIPBL ZNF121 MYBL2	5.55e-06	1429	154	20	35140242
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZNF384 BCLAF1 ZBTB9 CHD1 ADNP CHAMP1 RAD51AP1 ZNF644 SMARCA4 SMARCC1 DDX21 SNRNP200 NIPBL FKBP3 NOL8 MYBL2	5.68e-06	954	154	16	36373674
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	NCOA2 ADNP CHAMP1 KMT2C SMARCC1 STIP1 SNRNP200 HDAC1	6.67e-06	220	154	8	35785414
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	ADNP CHAMP1 ZNF644 SMARCA4 SMARCC1 HDAC1	6.86e-06	103	154	6	32744500
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NCOA2 PDCD6IP ANK3 ARHGAP15 MAP4K3 PHTF2 PTPN23 RHOT2 COLGALT1 PTGS2 ASAP1 KMT2C FARP1 RASSF1 SMARCC1 DDX21 USP3	6.89e-06	1084	154	17	11544199
Pubmed	CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation.	ZNF644 SMARCA4 HDAC1	9.99e-06	10	154	3	19061646
Pubmed	Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.	SMARCA4 SMARCC1 HDAC1	9.99e-06	10	154	3	11238380
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT4 PDCD6IP ANK3 BCLAF1 COPE CNKSR2 CNNM3 OSBPL2 DOCK7 PRKCH SNRNP200 SDK1 PCDH9 NOL8	1.01e-05	777	154	14	35844135
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	ZNF384 BCLAF1 ZBTB9 ADNP CHAMP1 LDB1 FARP1 SMARCA4 SMARCC1 DDX21 SNRNP200 HDAC1	1.22e-05	583	154	12	29844126
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 PDCD6IP ZHX2 KMT2C NAA25 SMARCA4 SMARCC1 DDX20 STIP1 IFT122	1.22e-05	398	154	10	35016035
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	PDCD6IP BCLAF1 HMMR ADNP MRPS22 AAR2 TWF1 PALS1 KIAA1217 DOCK7 SMARCA4 PLEKHA5 TOPORS DDX21 SNRNP200 FKBP3 HDAC1 NOL8	1.25e-05	1257	154	18	36526897
Pubmed	A census of human transcription factors: function, expression and evolution.	ZNF384 ZHX2 ADNP PRDM5 ZNF25 MEIS2 SIX6 THAP11 ZNF28 NEUROD2 ZNF644 SKOR1 ATF4 ZBED1 MYBL2	1.35e-05	908	154	15	19274049
Pubmed	Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.	SMARCA4 SMARCC1 HDAC1	1.37e-05	11	154	3	10204490
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	BCLAF1 ZNF423 CHD1 ADNP MEIS2 SMARCA4 SMARCC1 TOPORS SNRNP200 HDAC1	1.61e-05	411	154	10	35182466
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MYH2 FAM120B PDCD6IP BCLAF1 TWF2 CHD1 CNKSR2 MRPS22 CNNM3 KMT2C LIG4 NAA25 SMARCA4 SMARCC1 DDX20 STIP1 DDX21 SNRNP200	1.66e-05	1284	154	18	17353931
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	BCLAF1 WDR70 ZBTB9 TWF2 ADNP TWF1 DOCK7 SMARCA4 SMARCC1 DDX21 SNRNP200	1.72e-05	506	154	11	30890647
Pubmed	Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients.	PTGS2 LIG4 EGF	1.82e-05	12	154	3	16407418
Pubmed	Conditional Loss of BAF (mSWI/SNF) Scaffolding Subunits Affects Specification and Proliferation of Oligodendrocyte Precursors in Developing Mouse Forebrain.	PDGFRA SMARCA4 SMARCC1	1.82e-05	12	154	3	34336815
Pubmed	Human Fc gamma RIII: cloning, expression, and identification of the chromosomal locus of two Fc receptors for IgG.	FCGR3A FCGR3B	1.95e-05	2	154	2	2521732
Pubmed	Increased reprogramming capacity of mouse liver progenitor cells, compared with differentiated liver cells, requires the BAF complex.	SMARCA4 SMARCC1	1.95e-05	2	154	2	22245845
Pubmed	Cloning, expression and characterization of an A6-related protein.	TWF2 TWF1	1.95e-05	2	154	2	10406962
Pubmed	Two biochemically distinct and tissue-specific twinfilin isoforms are generated from the mouse Twf2 gene by alternative promoter usage.	TWF2 TWF1	1.95e-05	2	154	2	18837697
Pubmed	Single-cell analyses identify dysfunctional CD16+ CD8 T cells in smokers.	FCGR3A FCGR3B	1.95e-05	2	154	2	33163982
Pubmed	Association study of copy number variants in FCGR3A and FCGR3B gene with risk of ankylosing spondylitis in a Chinese population.	FCGR3A FCGR3B	1.95e-05	2	154	2	26494566
Pubmed	ATF4-mediated histone deacetylase HDAC1 promotes the progression of acute pancreatitis.	ATF4 HDAC1	1.95e-05	2	154	2	33414424
Pubmed	COX-2 expression induced by diesel particles involves chromatin modification and degradation of HDAC1.	PTGS2 HDAC1	1.95e-05	2	154	2	17395887
Pubmed	Impact of allele copy number of polymorphisms in FCGR3A and FCGR3B genes on susceptibility to ulcerative colitis.	FCGR3A FCGR3B	1.95e-05	2	154	2	23917248
Pubmed	MAP4K3/GLK inhibits Treg differentiation by direct phosphorylating IKKβ and inducing IKKβ-mediated FoxO1 nuclear export and Foxp3 downregulation.	MAP4K3 GCK	1.95e-05	2	154	2	35966593
Pubmed	Evidence for gene recombination in FCGR3 gene variants.	FCGR3A FCGR3B	1.95e-05	2	154	2	19320901
Pubmed	Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes.	FCGR3A FCGR3B	1.95e-05	2	154	2	25966632
Pubmed	The Fc gamma receptor of natural killer cells is a phospholipid-linked membrane protein.	FCGR3A FCGR3B	1.95e-05	2	154	2	2967436
Pubmed	Twinfilin 2a regulates platelet reactivity and turnover in mice.	TWF2 TWF1	1.95e-05	2	154	2	28743718
Pubmed	The cyclic nucleotide-binding homology domain of the integral membrane protein CNNM mediates dimerization and is required for Mg2+ efflux activity.	CNNM2 CNNM3	1.95e-05	2	154	2	30341174
Pubmed	Low copy numbers of FCGR3A and FCGR3B associated with Chinese patients with SLE and AASV.	FCGR3A FCGR3B	1.95e-05	2	154	2	28355982
Pubmed	The human low affinity immunoglobulin G Fc receptor III-A and III-B genes. Molecular characterization of the promoter regions.	FCGR3A FCGR3B	1.95e-05	2	154	2	7836402
Pubmed	Identification of an ADAM17 cleavage region in human CD16 (FcγRIII) and the engineering of a non-cleavable version of the receptor in NK cells.	FCGR3A FCGR3B	1.95e-05	2	154	2	25816339
Pubmed	Evi3, a common retroviral integration site in murine B-cell lymphoma, encodes an EBFAZ-related Krüppel-like zinc finger protein.	ZNF423 ZNF521	1.95e-05	2	154	2	12393497
Pubmed	Twinfilin, a molecular mailman for actin monomers.	TWF2 TWF1	1.95e-05	2	154	2	11870207
Pubmed	The loss of the CD16 B73.1/Leu11c epitope occurring in some primary immunodeficiency diseases is not associated with the FcgammaRIIIa-48L/R/H polymorphism.	FCGR3A FCGR3B	1.95e-05	2	154	2	20664961
Pubmed	FCGR Genetic Variation in Two Populations From Ecuador Highlands-Extensive Copy-Number Variation, Distinctive Distribution of Functional Polymorphisms, and a Novel, Locally Common, Chimeric FCGR3B/A (CD16B/A) Gene.	FCGR3A FCGR3B	1.95e-05	2	154	2	34108956
Pubmed	Versatile roles of R-Ras GAP in neurite formation of PC12 cells and embryonic vascular development.	RASA1 RASA3	1.95e-05	2	154	2	17179160
Pubmed	BRG1 Governs Nanog Transcription in Early Mouse Embryos and Embryonic Stem Cells via Antagonism of Histone H3 Lysine 9/14 Acetylation.	SMARCA4 HDAC1	1.95e-05	2	154	2	26416882
Pubmed	The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential.	FCGR3A FCGR3B	1.95e-05	2	154	2	23770975
Pubmed	Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis.	FCGR3A FCGR3B	1.95e-05	2	154	2	22290871
Pubmed	Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis.	FCGR3A FCGR3B	1.95e-05	2	154	2	20980704
Pubmed	Nucleotide sequence of a new Fc gamma receptor IIIB allele that codes for a neutrophil antigen.	FCGR3A FCGR3B	1.95e-05	2	154	2	11034564
Pubmed	Separate promoters from proximal and medial control regions contribute to the natural killer cell-specific transcription of the human FcgammaRIII-A (CD16-A) receptor gene.	FCGR3A FCGR3B	1.95e-05	2	154	2	8940055
Pubmed	FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis.	FCGR3A FCGR3B	1.95e-05	2	154	2	27059607
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network.	SMARCA4 SMARCC1	1.95e-05	2	154	2	19279218
Pubmed	Mammals have two twinfilin isoforms whose subcellular localizations and tissue distributions are differentially regulated.	TWF2 TWF1	1.95e-05	2	154	2	12807912
Pubmed	The SWI/SNF-like BAF complex is essential for early B cell development.	SMARCA4 SMARCC1	1.95e-05	2	154	2	22427636
Pubmed	COX2 and PGE2 mediate EGF-induced E-cadherin-independent human ovarian cancer cell invasion.	PTGS2 EGF	1.95e-05	2	154	2	24969217
Pubmed	Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients.	FCGR3A FCGR3B	1.95e-05	2	154	2	25154742
Pubmed	A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.	FCGR3A FCGR3B	1.95e-05	2	154	2	2525780
Pubmed	Endoplasmic reticulum stress induced by hepatitis B virus X protein enhances cyclo-oxygenase 2 expression via activating transcription factor 4.	PTGS2 ATF4	1.95e-05	2	154	2	21244365
Pubmed	FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma.	FCGR3A FCGR3B	1.95e-05	2	154	2	12445195
Pubmed	Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions.	FCGR3A FCGR3B	1.95e-05	2	154	2	2526846
Pubmed	B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.	FCGR3A FCGR3B	1.95e-05	2	154	2	18292508
Pubmed	Opposing calcium-dependent signalling pathways control skeletal muscle differentiation by regulating a chromatin remodelling enzyme.	SMARCA4 PRKCB	1.95e-05	2	154	2	26081415
Pubmed	Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations.	ZBTB9 ADNP CHAMP1 ZNF644 HDAC1 MYBL2	2.08e-05	125	154	6	32891193
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	ZBTB9 ADNP CHAMP1 AAR2 SMARCA4 DDX21 SNRNP200 HDAC1 MYBL2	2.19e-05	339	154	9	30415952
Pubmed	EGF-stimulated signaling by means of PI3K, PLCgamma1, and PKC isozymes regulates branching morphogenesis of the fetal mouse submandibular gland.	EGF PRKCB PRKCH	2.36e-05	13	154	3	12761849
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	CHD1 ADNP MRPS22 NAA25 MDN1 SMARCA4 SMARCC1 INTS9 SNRNP200 NIPBL HDAC1	2.77e-05	533	154	11	30554943
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	NCOA2 MYH2 FAT4 TRPC4AP PDCD6IP RHOT2 PRDM5 MDN1 SMARCC1 FGD5 NIPBL MYBL2	2.95e-05	638	154	12	31182584
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 DUSP9 WDR70 ADNP LIG4 MDN1 LDB1 ZNF644 SMARCA4 SMARCC1 CABIN1 DDX21 SNRNP200 MYBL2	2.99e-05	857	154	14	25609649
Pubmed	Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.	SMARCA4 SMARCC1 HDAC1	3.73e-05	15	154	3	17255939
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	ZNF384 PDCD6IP BCLAF1 PTPN23 TWF2 HMMR ADNP CHAMP1 MRPS22 ASAP1 TWF1 NAA25 SMARCC1 DDX20 STIP1 DDX21 FKBP3 HDAC1	3.77e-05	1367	154	18	32687490
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	BCLAF1 WDR70 ADNP CHAMP1 SMARCA4 DDX21 SNRNP200 NOL8	4.07e-05	283	154	8	30585729
Pubmed	The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.	ZNF384 ADNP CHAMP1 DDX21 NIPBL	4.16e-05	86	154	5	37253089
Pubmed	A novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1.	SMARCA4 SMARCC1 HDAC1	4.57e-05	16	154	3	11013263
Pubmed	Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1).	SMARCA4 SMARCC1 HDAC1	4.57e-05	16	154	3	11784859
Pubmed	Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.	SMARCA4 SMARCC1 HDAC1	4.57e-05	16	154	3	35390516
Interaction	PAX6 interactions	ZBTB9 ZNF521 ZHX2 MEIS2 SPG21 KMT2C LDB1 ZNF644 SMARCA4 SMARCC1 CABIN1 ZBED1 NIPBL ZNF121 MYBL2	1.33e-07	366	153	15	int:PAX6
Interaction	HNF4A interactions	NCOA2 ZBTB9 ZNF521 ZHX2 ADNP KMT2C ZNF644 SMARCA4 SMARCC1 CABIN1 NIPBL MYBL2	1.31e-06	275	153	12	int:HNF4A
Interaction	ERG interactions	NCOA2 ZNF521 KMT2C NEUROD2 LDB1 SMARCA4 SMARCC1 DDX21 SNRNP200 NIPBL	8.13e-06	223	153	10	int:ERG
Interaction	TFCP2L1 interactions	ADNP CHAMP1 SMARCA4 SMARCC1 CABIN1 HDAC1 MYBL2	1.05e-05	99	153	7	int:TFCP2L1
Interaction	MYOD1 interactions	NCOA2 KMT2C ZNF644 SMARCA4 SMARCC1 CABIN1 NIPBL HDAC1 ZNF121	1.78e-05	194	153	9	int:MYOD1
Interaction	TBXT interactions	NCOA2 KMT2C LDB1 ZNF644 SMARCA4 SMARCC1 NIPBL	2.96e-05	116	153	7	int:TBXT
Interaction	SLX4 interactions	ZNF384 PDCD6IP WDR70 ZBTB9 CHD1 ADNP CHAMP1 MDN1 ZNF644 SMARCA4 SMARCC1 SNRNP200 NIPBL NOL8 MYBL2	3.14e-05	572	153	15	int:SLX4
Interaction	EGR2 interactions	NCOA2 ZBTB9 ZNF521 KMT2C LDB1 ZNF644 SMARCC1 NIPBL	4.97e-05	171	153	8	int:EGR2
Interaction	H3-3A interactions	ZNF384 PDGFRA WDR70 ZBTB9 CHD1 ADNP CHAMP1 RAD51AP1 KMT2C ZNF644 SMARCA4 SMARCC1 CABIN1 USP3 NIPBL HDAC1 MYBL2	5.65e-05	749	153	17	int:H3-3A
Interaction	TLX1 interactions	NCOA2 MRPS22 MEIS2 KMT2C LDB1 ZNF644 SMARCC1 NIPBL	5.85e-05	175	153	8	int:TLX1
Cytoband	12p12	ZNF384 PLEKHA5	8.51e-04	13	154	2	12p12
Cytoband	19p13.2	ZNF441 ZNF846 SMARCA4 ZNF799 ZNF443	1.09e-03	229	154	5	19p13.2
Cytoband	10q21	ANK3 DDX21	1.30e-03	16	154	2	10q21
Cytoband	1q23	FCGR3A FCGR3B	2.70e-03	23	154	2	1q23
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF729 ZNF384 ZNF573 ZNF337 ZNF366 ZNF423 ZBTB9 ZNF521 ZHX2 PRDM5 CHAMP1 ZNF25 ZNF365 ZNF529 ZNF441 ZNF28 ZNF846 ZNF799 ZNF443 ZNF121	1.54e-08	718	112	20	28
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASA1 ARHGAP15 RASA3 CNKSR2 ASAP1 PLEKHG1 FARP1 PLEKHA5 FGD5 ARHGEF4	6.11e-07	206	112	10	682
GeneFamily	Mitogen-activated protein kinase kinase kinase kinases	MAP4K3 MAP4K5	3.76e-04	5	112	2	655
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	PLEKHG1 FARP1 FGD5 ARHGEF4	7.48e-04	66	112	4	722
GeneFamily	C2 domain containing protein kinases	PRKCB PRKCH	1.66e-03	10	112	2	835
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA1 RASA3	1.66e-03	10	112	2	830
GeneFamily	Ras association domain family	RASSF6 RASSF1	1.66e-03	10	112	2	1198
GeneFamily	Myosin heavy chains	MYH2 MYH3	3.79e-03	15	112	2	1098
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZHX2 ADNP	3.79e-03	15	112	2	529
GeneFamily	Cadherin related	FAT4 FAT3	4.87e-03	17	112	2	24
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	SYCP2L ANK3 RASA1 PDGFRA BCLAF1 COX7B SAXO2 CNKSR2 ADNP PRDM5 MRPS22 RAD51AP1 ST6GAL2 LIG4 MDN1 ZNF644 ZNF846 TLL1 DOCK7 SMARCC1 TOPORS USP3 NIPBL FKBP3 NOL8	1.97e-06	1241	150	25	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	RASA1 BCLAF1 CHD1 ZSWIM6 ZHX2 RAD51AP1 PALS1 SMARCC1 INTS9 STIP1 ZC3H12C TOPORS NIPBL FKBP3 NOL8	5.76e-06	532	150	15	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	SYCP2L ANK3 RASA1 PDGFRA BCLAF1 DUSP9 COX7B SAXO2 CNKSR2 ADNP PRDM5 MRPS22 RAD51AP1 ST6GAL2 LIG4 MDN1 ZNF644 ZNF846 TLL1 DOCK7 SMARCC1 TOPORS USP3 NIPBL FKBP3 NOL8	1.22e-05	1468	150	26	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	NCOA2 RASA1 BCLAF1 ZNF423 FAT3 CHD1 NCKAP5 HMMR RAD51AP1 ST6GAL2 ZNF644 TLL1 DOCK7 SMARCC1 STIP1 ZC3H12C USP3 NIPBL NOL8 MYBL2	5.86e-05	1060	150	20	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NCOA2 FAT4 BCLAF1 FAT3 CHD1 NCKAP5 ZSWIM6 MEIS2 ST6GAL2 PALS1 TLL1 STIP1 ZC3H12C PCDH9 NOL8	6.33e-05	654	150	15	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	ZNF729 RASA1 COL6A6 BCLAF1 SAXO2 CHD1 CNKSR2 HMMR ADNP PRDM5 RAD51AP1 ST6GAL2 MDN1 ZNF644 ZNF846 TLL1 DOCK7 SMARCC1 STIP1 IFT122 USP3 NIPBL	6.98e-05	1252	150	22	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst-Confounder_removed-fold2.0_adjp0.05	NEBL ZNF423 PHTF2 ZNF521 CHD1 ZSWIM6 KIAA1586 ADNP ZNF529 MEIS2 SIX6 PLEKHG1 RAD51AP1 NAA25 MDN1 LDB1 FAM161A ZNF644 DOCK7 SMARCC1 TRMT13 DDX21 ZNF443 ZNF121	1.10e-04	1479	150	24	PCBC_ratio_MESO-15 amniotic fluid MSC_vs_MESO-15 blastocyst_cfr-2X-p05
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	4.79e-11	184	154	11	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	8.46e-11	194	154	11	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	9.45e-11	196	154	11	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.43e-09	192	154	10	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 CETP ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	1.43e-09	192	154	10	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.43e-09	192	154	10	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 NCKAP5 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.50e-09	193	154	10	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 CETP ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	1.50e-09	193	154	10	52e918884877b6659cdca0496390e440f73694a9
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 NCKAP5 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.50e-09	193	154	10	e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.50e-09	193	154	10	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 NCKAP5 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.50e-09	193	154	10	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF366 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	1.50e-09	193	154	10	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5 ZC3H12C	1.58e-09	194	154	10	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5 ZC3H12C	1.58e-09	194	154	10	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	1.58e-09	194	154	10	f5706ab6bc803606c4640ddd606617e4e797ccc9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	1.58e-09	194	154	10	f76808666fb875fc787751cbfd924d9be20a8192
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 CETP ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	1.74e-09	196	154	10	023312af38f816a44b407e0daa32590d953caf99
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	1.83e-09	197	154	10	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	1.83e-09	197	154	10	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	1.92e-09	198	154	10	0a172c6d997c7cfbad34b56e80121bd104dee67d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	2.21e-08	190	154	9	656483751e4bf137e4e4bfb2a03a478a8f7fcb63
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	2.31e-08	191	154	9	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYCP2L ZNF366 ZNF521 MEIS2 PLEKHG1 KIAA1217 TLL1 PRKCH FGD5	2.31e-08	191	154	9	2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.42e-08	192	154	9	28eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 BLOC1S6 TLL1 PDIA5 PRKCH FGD5	2.42e-08	192	154	9	1ee4783051ec94ea94600f040edcb385fc4289f1
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 NCKAP5 MEIS2 KIAA1217 PRKCH FGD5 ZC3H12C	2.53e-08	193	154	9	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	2.53e-08	193	154	9	1f978e102a029a6beb10913052cd0a20c7253e8e
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5 ZC3H12C	2.53e-08	193	154	9	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5 ZC3H12C	2.53e-08	193	154	9	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	2.64e-08	194	154	9	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	2.64e-08	194	154	9	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 NCKAP5 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	2.64e-08	194	154	9	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 ZNF423 ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	2.64e-08	194	154	9	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	2.64e-08	194	154	9	fa6d51f36a3dae8763a595c20892987ed454c0f0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 CETP ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	2.64e-08	194	154	9	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT4 ZNF423 ZNF521 MEIS2 PLEKHG1 KIAA1217 TLL1 PRKCH FGD5	2.76e-08	195	154	9	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	SYCP2L ZNF366 ZNF521 DENND3 MEIS2 PLEKHG1 TLL1 PRKCH FGD5	2.76e-08	195	154	9	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.89e-08	196	154	9	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.89e-08	196	154	9	ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.89e-08	196	154	9	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ANK3 NEBL MAP4K3 WDR70 ZSWIM6 ZHX2 CAMKMT SDK1	2.89e-08	196	154	9	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.89e-08	196	154	9	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	SYCP2L ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.89e-08	196	154	9	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ZNF366 ZNF521 MEIS2 PLEKHG1 TLL1 PDIA5 PRKCH FGD5	2.89e-08	196	154	9	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.89e-08	196	154	9	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	3.02e-08	197	154	9	0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYCP2L ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PDIA5 PRKCH FGD5	3.15e-08	198	154	9	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	3.15e-08	198	154	9	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	3.15e-08	198	154	9	07701c73137947ed4a27e225975329235bbb8734
ToppCell	Parenchymal-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	3.29e-08	199	154	9	a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 ZNF521 GCK MEIS2 ASAP1 PDIA5 PRKCH FGD5	1.04e-07	163	154	8	73c03e29a6d7a6863c5e9aa5e8b963ef691f1ddb
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CAPN9 NEBL NCKAP5 DENND3 ST6GAL2 FARP1 ZC3H12C ARHGEF4	2.13e-07	179	154	8	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.13e-07	179	154	8	8f9e538c822940785130297712b75131812a4603
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYCP2L DENND3 MEIS2 PLEKHG1 KIAA1217 TLL1 PRKCH FGD5	2.23e-07	180	154	8	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	COVID-19-kidney-Mito-rich_EC\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF366 ZNF423 ZNF521 MEIS2 PLEKHG1 TLL1 PRKCH FGD5	2.53e-07	183	154	8	3c4153479fc4ab2d073d92cee120480015555914
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 ADNP NEUROD2 FCGR3A RASSF1 PRKCH PCDH9 ZNF121	2.98e-07	187	154	8	b426a67b5669019115b58295ce7d304beeb75825
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	2.98e-07	187	154	8	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	NCOA2 ANK3 NEBL EGF FARP1 KIAA1217 CAMKMT PCDH9	3.23e-07	189	154	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF521 IFIT3 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5 ZC3H12C	3.36e-07	190	154	8	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT4 ZNF423 ZNF521 MEIS2 PLEKHG1 TLL1 PRKCH FGD5	3.36e-07	190	154	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|kidney / Disease (COVID-19 only), tissue and cell type	FAT4 ZNF366 PTGS2 MEIS2 FGL2 PLEKHG1 PRKCH FGD5	3.36e-07	190	154	8	1519f34d31fe0817184c5865a0bc9f0cb479b1a4
ToppCell	COVID-19-Endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ZNF366 ZNF423 MEIS2 PLEKHG1 KIAA1217 TLL1 PRKCH FGD5	3.36e-07	190	154	8	9fbd92cd6d4683b2490504d29c43cf42020433d4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 ADNP NEUROD2 FCGR3A RASSF1 PRKCH PCDH9 ZNF121	3.36e-07	190	154	8	600b9674197f743dea1d19d3df0fc993b6e6aa25
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 ADNP NEUROD2 FCGR3A RASSF1 PRKCH PCDH9 ZNF121	3.64e-07	192	154	8	97c312c82ec025c13052f8d424b11c0034c8ea54
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYCP2L ZNF366 ZNF423 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	3.64e-07	192	154	8	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PDIA5 PRKCH	3.64e-07	192	154	8	25cb6cc6cbf8dc20139d938adfc02ed7a8c3dfb6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 ADNP NEUROD2 FCGR3A RASSF1 PRKCH PCDH9 ZNF121	3.64e-07	192	154	8	c5f77c2103841505d13e09173549811312ef2f01
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNNM2 ADNP NEUROD2 FCGR3A RASSF1 PRKCH PCDH9 ZNF121	3.64e-07	192	154	8	e981162f387a31111c0ae8355dbe9db5785c4838
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 RASA1 ARHGAP15 MAP4K3 ZSWIM6 ZHX2 ASAP1 KMT2C	3.79e-07	193	154	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	3.79e-07	193	154	8	287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	3.94e-07	194	154	8	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 TLL1 PDIA5 PRKCH FGD5	3.94e-07	194	154	8	ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	4.26e-07	196	154	8	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 TLL1 PDIA5 PRKCH FGD5	4.26e-07	196	154	8	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 TLL1 PDIA5 PRKCH FGD5	4.26e-07	196	154	8	473980c827443464d08a0be28c53e3536369b12a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	4.26e-07	196	154	8	145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 TLL1 PDIA5 PRKCH FGD5	4.26e-07	196	154	8	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	4.26e-07	196	154	8	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COVID-19-lung-Capillary_1\|lung / Disease (COVID-19 only), tissue and cell type	FAT4 ZNF366 ZNF423 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	4.43e-07	197	154	8	7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	4.43e-07	197	154	8	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	4.43e-07	197	154	8	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYCP2L ZNF366 ZNF423 MEIS2 PLEKHG1 KIAA1217 PRKCH FGD5	4.60e-07	198	154	8	1d30a1f73b6d6d838f49751402a29c5ef54aa81f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	4.60e-07	198	154	8	b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ZNF366 MEIS2 ASAP1 PLEKHG1 PDIA5 PRKCH FGD5	4.60e-07	198	154	8	92416e65a0dc1a4bf931833407620ea05d362f56
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYCP2L ZNF366 ZNF423 MEIS2 PLEKHG1 KIAA1217 TLL1 FGD5	4.60e-07	198	154	8	a1ccbf0e653b2dd665c2254920eb9b37243cc0bd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	4.60e-07	198	154	8	953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ZNF366 ZNF423 ZNF521 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	4.60e-07	198	154	8	8689090bce9ab6e8f122426a404037e572c6713b
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 TLL1 PRKCH FGD5	4.60e-07	198	154	8	8e45551224fbb30c0658ad47dd98335ecf165437
ToppCell	Bronchial-NucSeq-Endothelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF366 ZNF423 MEIS2 ASAP1 PLEKHG1 KIAA1217 TLL1 FGD5	4.78e-07	199	154	8	36a230b80096455df26c2e2c8c05fd6b231508c5
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 ANK3 MAP4K3 WDR70 ZSWIM6 ZHX2 KMT2C CAMKMT	4.78e-07	199	154	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	COVID-19-lung-Capillary_2\|lung / Disease (COVID-19 only), tissue and cell type	ZNF366 ZNF423 MEIS2 PLEKHG1 KIAA1217 TLL1 PRKCH FGD5	4.78e-07	199	154	8	793ce71b78a68033ef4419ed571e1dd86b40124f
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FAT4 ZNF521 NCKAP5 MEIS2 KMT2C KIAA1217 PRKCH NIPBL	4.96e-07	200	154	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF423 ZNF521 MEIS2 PDIA5 PRKCH FGD5	1.22e-06	156	154	7	f894fac4e44a23718b20ad80c9677bf4f2118002
ToppCell	normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs\|normal_Pleural_Fluid / Location, Cell class and cell subclass	ZNF366 ZNF423 NCKAP5 PANX2 ASAP1 FGL2 FGD5	2.72e-06	176	154	7	195393b38f1335f2cb96125616d75c164a6026c2
ToppCell	IIH-mDC1-\|IIH / Condition, Cell_class and T cell subcluster	ZNF366 CETP ZNF423 PANX2 ASAP1 FGL2 SMPDL3B	2.72e-06	176	154	7	bb80a3e595d071f6cc8b042984b8d9490e377eef
ToppCell	IIH-mDC1\|IIH / Condition, Cell_class and T cell subcluster	ZNF366 CETP ZNF423 PANX2 ASAP1 FGL2 SMPDL3B	2.72e-06	176	154	7	a75dc132a1061006fd1cb305bd314784fca07ea6
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF366 PTGS2 MEIS2 FGL2 PLEKHG1 PRKCH FGD5	3.04e-06	179	154	7	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF366 ZNF521 MEIS2 ASAP1 PLEKHG1 PRKCH FGD5	3.16e-06	180	154	7	16728b9a1c52097e3a460534be71a476ecc54f0f
ToppCell	NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ZNF366 ZSWIM6 PRDM5 IFIT3 FGL2 FCGR3A LILRB4	3.40e-06	182	154	7	e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZNF366 ZNF423 ZNF521 PLEKHG1 TLL1 PRKCH FGD5	3.52e-06	183	154	7	ff95382cfed592190d0636d2b750328471f82e0d
Drug	irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A	NCOA2 SPRED2 RASA1 MAP4K3 WDR70 CHD1 ZHX2 MDN1 PLEKHA5 NIPBL	4.97e-07	183	154	10	7498_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; PC3; HT_HG-U133A	CAPN9 POMT2 NPR2 PDGFRA COLGALT1 LDB1 SMARCA4 CAMKMT ARHGEF4 PCDH9	9.76e-07	197	154	10	4598_UP
Disease	triglycerides to total lipids in medium VLDL percentage	CETP RGS12 MAP4K5 DOCK7 SMARCA4 STIP1	9.03e-07	63	152	6	EFO_0022335
Disease	total phospholipids in lipoprotein particles measurement	CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	7.98e-06	53	152	5	EFO_0022315
Disease	lung non-small cell carcinoma (is_implicated_in)	NCOA2 PTGS2 KMT2C EGF RASSF1 SMARCA4 PRKCB	8.10e-06	139	152	7	DOID:3908 (is_implicated_in)
Disease	free cholesterol to total lipids in medium VLDL percentage	CETP RGS12 MAP4K5 DOCK7 SMARCA4	1.15e-05	57	152	5	EFO_0022284
Disease	Hyperglycemia, Postprandial	GCK PTGS2 FCGR3B PRKCB	1.67e-05	30	152	4	C1855520
Disease	Hyperglycemia	GCK PTGS2 FCGR3B PRKCB	1.67e-05	30	152	4	C0020456
Disease	cholesterol to total lipids in medium VLDL percentage	RGS12 MAP4K5 DOCK7 SMARCA4 STIP1	1.88e-05	63	152	5	EFO_0022239
Disease	Familial primary hypomagnesemia with normocalciuria and normocalcemia	CNNM2 EGF	2.64e-05	2	152	2	C4510731
Disease	level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum	FCGR3A FCGR3B	2.64e-05	2	152	2	OBA_2040305
Disease	Carcinoma, Granular Cell	FAT4 PTGS2 KMT2C EGF RASSF1 SMARCC1	3.15e-05	116	152	6	C0205644
Disease	Adenocarcinoma, Tubular	FAT4 PTGS2 KMT2C EGF RASSF1 SMARCC1	3.15e-05	116	152	6	C0205645
Disease	Adenocarcinoma, Oxyphilic	FAT4 PTGS2 KMT2C EGF RASSF1 SMARCC1	3.15e-05	116	152	6	C0205642
Disease	Carcinoma, Cribriform	FAT4 PTGS2 KMT2C EGF RASSF1 SMARCC1	3.15e-05	116	152	6	C0205643
Disease	Adenocarcinoma, Basal Cell	FAT4 PTGS2 KMT2C EGF RASSF1 SMARCC1	3.15e-05	116	152	6	C0205641
Disease	Adenocarcinoma	FAT4 PTGS2 KMT2C EGF RASSF1 SMARCC1	3.15e-05	116	152	6	C0001418
Disease	docosahexaenoic acid measurement	SYCP2L CETP WDR70 MAP4K5 DOCK7 SMARCA4	5.24e-05	127	152	6	EFO_0007761
Disease	polyunsaturated fatty acid measurement	CETP TMPRSS11E NAA25 MAP4K5 DOCK7 SMARCA4	6.23e-05	131	152	6	EFO_0010733
Disease	alcohol use disorder (implicated_via_orthology)	RASA1 MAP4K3 MAP4K5 SMARCA4 SMARCC1 PRKCB PRKCH	7.13e-05	195	152	7	DOID:1574 (implicated_via_orthology)
Disease	free cholesterol to total lipids in very small VLDL percentage	CETP MAP4K5 DOCK7 SMARCA4	7.14e-05	43	152	4	EFO_0022290
Disease	Lupus Vasculitis, Central Nervous System	FCGR3A FCGR3B	7.88e-05	3	152	2	C0752332
Disease	Lupus Meningoencephalitis	FCGR3A FCGR3B	7.88e-05	3	152	2	C0752334
Disease	Neuropsychiatric Systemic Lupus Erythematosus	FCGR3A FCGR3B	7.88e-05	3	152	2	C0752335
Disease	lipoprotein measurement, phospholipid measurement	CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	7.99e-05	85	152	5	EFO_0004639, EFO_0004732
Disease	Fetal Alcohol Syndrome	ANK3 PDGFRA ADNP	8.64e-05	17	152	3	C0015923
Disease	phospholipid measurement	CETP TMPRSS11E NAA25 MAP4K5 DOCK7 SMARCA4	9.00e-05	140	152	6	EFO_0004639
Disease	physical activity	ZNF521 AAR2 PLEKHG1 FARP1 NIPBL	9.43e-05	88	152	5	EFO_0003940
Disease	Kidney Diseases	CNNM2 PTGS2 RGN EGF IFT122	9.43e-05	88	152	5	C0022658
Disease	lipid measurement, lipoprotein measurement	CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	1.05e-04	90	152	5	EFO_0004529, EFO_0004732
Disease	total lipids in lipoprotein particles measurement	CETP MAP4K5 DOCK7 SMARCA4	1.10e-04	48	152	4	EFO_0022309
Disease	phosphoglycerides measurement	CETP TMPRSS11E MAP4K5 DOCK7	1.10e-04	48	152	4	EFO_0022291
Disease	cholesteryl esters to total lipids in small VLDL percentage	CETP MAP4K5 DOCK7 SMARCA4	1.20e-04	49	152	4	EFO_0022256
Disease	attention function measurement	NCOA2 PHTF2 CNKSR2 ASAP1 KIAA1217 ARHGEF4	1.22e-04	148	152	6	EFO_0007636
Disease	cholesterol to total lipids in small VLDL percentage	CETP MAP4K5 DOCK7 SMARCA4	1.40e-04	51	152	4	EFO_0022242
Disease	Malignant neoplasm of breast	NCOA2 ZNF366 HMMR PANX2 ZNF25 ZNF365 PTGS2 MRPS22 NAA25 EGF FARP1 ZNF644 TLL1 FGD5 ARHGEF4 NIPBL	1.42e-04	1074	152	16	C0006142
Disease	cholesterol to total lipids in very large VLDL percentage	CETP MAP4K5 DOCK7 SMARCA4	1.75e-04	54	152	4	EFO_0022244
Disease	spontaneous preterm birth	NCKAP5 KIAA1217 INTS9 TOPORS SDK1	1.81e-04	101	152	5	EFO_0006917
Disease	triglycerides in very large HDL measurement	CETP TMPRSS11E MAP4K5 DOCK7	1.88e-04	55	152	4	EFO_0022324
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TMPRSS11E GCK MAP4K5 DOCK7 SMARCA4 USP3	2.28e-04	166	152	6	EFO_0004530, EFO_0004611
Disease	low density lipoprotein particle size measurement	CETP NAA25 MAP4K5 SMARCA4	2.31e-04	58	152	4	EFO_0008593
Disease	triglycerides to total lipids in small VLDL percentage	CETP MAP4K5 DOCK7 SMARCA4	2.31e-04	58	152	4	EFO_0022338
Disease	free cholesterol to total lipids in very large VLDL percentage	CETP RGS12 MAP4K5 SMARCA4	2.47e-04	59	152	4	EFO_0022289
Disease	unipolar depression, neuroticism measurement	DPP10 ZNF366 KIAA1217	2.51e-04	24	152	3	EFO_0003761, EFO_0007660
Disease	triglycerides to total lipids in large HDL percentage	CETP RGS12 MAP4K5 DOCK7	2.64e-04	60	152	4	EFO_0022330
Disease	coronary artery disease, factor VII measurement	CNNM2 CETP NAA25 MAP4K5 SMARCA4	2.81e-04	111	152	5	EFO_0001645, EFO_0004619
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	CETP MAP4K5 DOCK7 SMARCA4	2.81e-04	61	152	4	EFO_0008317, EFO_0008596, EFO_0020946
Disease	body weight	CNNM2 ARHGAP15 ZNF423 DUSP9 WDR70 ZNF521 CNKSR2 ZSWIM6 PRDM5 NAA25 MAP4K5 TBC1D1 KIAA1217 TLL1 CAMKMT DDX20 NIPBL	2.83e-04	1261	152	17	EFO_0004338
Disease	free cholesterol in very large HDL measurement	CETP MAP4K5 DOCK7 SMARCA4	2.99e-04	62	152	4	EFO_0022273
Disease	free cholesterol measurement	CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	3.05e-04	113	152	5	EFO_0008591
Disease	low density lipoprotein cholesterol measurement, lipid measurement	CETP TFR2 MAP4K5 DOCK7 SMARCA4	3.17e-04	114	152	5	EFO_0004529, EFO_0004611
Disease	total cholesterol measurement, low density lipoprotein cholesterol measurement	CETP TFR2 MAP4K5 DOCK7 SMARCA4	3.17e-04	114	152	5	EFO_0004574, EFO_0004611
Disease	antihyperlipidemic drug use measurement	CETP TMPRSS11E RASSF6 DOCK7 SMARCA4	3.30e-04	115	152	5	EFO_0803367
Disease	cholesteryl esters to total lipids in medium VLDL percentage	RGS12 MAP4K5 DOCK7 STIP1	3.38e-04	64	152	4	EFO_0022253
Disease	achondroplasia (implicated_via_orthology)	NPR2 SPRED2	3.90e-04	6	152	2	DOID:4480 (implicated_via_orthology)
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	CETP TFR2 MAP4K5 DOCK7 SMARCA4	4.02e-04	120	152	5	EFO_0004611, EFO_0004639
Disease	fatty acid measurement, linoleic acid measurement	CETP NAA25 MAP4K5 SMARCA4	4.27e-04	68	152	4	EFO_0005110, EFO_0006807
Disease	triglycerides to total lipids in very small VLDL percentage	MAP4K5 DOCK7 SMARCA4 STIP1	4.51e-04	69	152	4	EFO_0022341
Disease	susceptibility to mononucleosis measurement	FAT4 ZBTB9 MDN1 PDIA5	4.51e-04	69	152	4	EFO_0008403
Disease	fatty acid measurement	CETP TMPRSS11E GCK GCNT4 RGS12 NAA25 MAP4K5 DOCK7 SMARCA4	4.52e-04	436	152	9	EFO_0005110
Disease	HMG CoA reductase inhibitor use measurement	CETP TMPRSS11E RGS12 MAP4K5 DOCK7 SMARCA4	4.56e-04	189	152	6	EFO_0009932
Disease	coronary artery disease	FAT4 CNNM2 TRPC4AP DPP10 SPRED2 ARHGAP15 PCNX3 CETP CNKSR2 PLEKHG1 NAA25 FARP1 KIAA1217 SMARCA4 FGD5 CABIN1	4.60e-04	1194	152	16	EFO_0001645
Disease	cholesteryl ester measurement, low density lipoprotein cholesterol measurement	CETP TFR2 MAP4K5 DOCK7 SMARCA4	5.03e-04	126	152	5	EFO_0004611, EFO_0010351
Disease	esterified cholesterol measurement	CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	5.40e-04	128	152	5	EFO_0008589
Disease	cholesteryl esters to total lipids in large LDL percentage	CETP MAP4K5 DOCK7	5.42e-04	31	152	3	EFO_0022249
Disease	low affinity immunoglobulin gamma Fc region receptor II-a/b measurement	FCGR3A FCGR3B	5.44e-04	7	152	2	EFO_0008211
Disease	neuropilin-1 measurement	MAP4K5 DOCK7	5.44e-04	7	152	2	EFO_0020603
Disease	choline measurement	CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	5.80e-04	130	152	5	EFO_0010116
Disease	triacylglycerol 54:5 measurement	MAP4K5 TBC1D1 PRKCB	5.96e-04	32	152	3	EFO_0010423
Disease	HOMA-IR	MRPS22 MAP4K5 KIAA1217	6.53e-04	33	152	3	EFO_0004501
Disease	phosphatidylcholine measurement	SYCP2L DPP10 CETP TMPRSS11E MAP4K5 DOCK7 SMARCA4	7.01e-04	284	152	7	EFO_0010226
Disease	primary dental caries	DPP10 PDCD6IP TLL1	7.13e-04	34	152	3	EFO_0600095
Disease	restless legs syndrome (implicated_via_orthology)	MEIS2 MEIS3P1	7.23e-04	8	152	2	DOID:0050425 (implicated_via_orthology)
Disease	1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement	CETP DOCK7	7.23e-04	8	152	2	EFO_0800610
Disease	procollagen galactosyltransferase 1 measurement	COLGALT1 SMARCC1	7.23e-04	8	152	2	EFO_0801922
Disease	1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement	CETP DOCK7	7.23e-04	8	152	2	EFO_0800396
Disease	memory impairment	FUT10 FAT4	7.23e-04	8	152	2	EFO_0001072
Disease	Attached earlobe	MRPS22 KIAA1217	7.23e-04	8	152	2	HP_0009907
Disease	level of Phosphatidylcholine (18:1_18:1) in blood serum	CETP DOCK7	7.23e-04	8	152	2	OBA_2045099
Disease	Abnormality of refraction	ANK3 NEBL FAT3 CNKSR2 ZSWIM6 DENND3 ASAP1 MAP4K5 TLL1 CAMKMT PCDH9	7.62e-04	673	152	11	HP_0000539
Disease	total lipids in small HDL measurement	CETP MAP4K5 DOCK7	7.77e-04	35	152	3	EFO_0022311
Disease	free cholesterol in small HDL measurement	CETP MAP4K5 DOCK7	7.77e-04	35	152	3	EFO_0022270
Disease	Cleft Palate	PDGFRA CHD1 MEIS2 EGF	8.28e-04	81	152	4	C0008925
Disease	cholesterol in small HDL measurement	CETP MAP4K5 DOCK7	8.45e-04	36	152	3	EFO_0022226
Disease	daytime rest measurement	FAM120B DPP10 ZNF521 CNKSR2 DENND3 PRKCB USP3	8.76e-04	295	152	7	EFO_0007828
Disease	cholesteryl esters to total lipids in medium LDL percentage	CETP MAP4K5 DOCK7	9.16e-04	37	152	3	EFO_0022252
Disease	apolipoprotein A-V measurement	CETP MAP4K5	9.27e-04	9	152	2	EFO_0801387
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA4 SMARCC1	9.27e-04	9	152	2	DOID:0050340 (implicated_via_orthology)
Disease	plexin-B2 measurement	FCGR3A FCGR3B	9.27e-04	9	152	2	EFO_0021867
Disease	phospholipids in small HDL measurement	CETP MAP4K5 DOCK7	9.91e-04	38	152	3	EFO_0022296
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	CETP TMPRSS11E MAP4K5 TBC1D1 DOCK7 SMARCA4	1.01e-03	220	152	6	EFO_0004529, EFO_0008317
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	MYH2 CETP RGS12 MAP4K5 DOCK7 SMARCA4	1.06e-03	222	152	6	EFO_0008317, EFO_0020943
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	RASA3 CETP GCK MAP4K5 DOCK7 SMARCA4	1.11e-03	224	152	6	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	CETP TMPRSS11E TWF2 MAP4K5 DOCK7 SMARCA4	1.11e-03	224	152	6	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	CETP TMPRSS11E TWF2 MAP4K5 DOCK7 SMARCA4	1.13e-03	225	152	6	EFO_0008317, EFO_0010351
Disease	cholesterol in very small VLDL measurement	CETP DOCK7 SMARCA4	1.15e-03	40	152	3	EFO_0022231
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH3	1.15e-03	10	152	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH3	1.15e-03	10	152	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH3	1.15e-03	10	152	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH3	1.15e-03	10	152	2	DOID:0110454 (implicated_via_orthology)
Disease	1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement	CETP MAP4K5	1.15e-03	10	152	2	EFO_0800464
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH3	1.15e-03	10	152	2	DOID:0080719 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KDKLTHKEHNHPSFY	C2orf16	1531	Q68DN1
FPENVYSVHFEKEHK	ADNP	456	Q9H2P0
YSVHFEKEHKAEKVP	ADNP	461	Q9H2P0
HVNKKGNAFIEHYDP	FAM228B	116	P0C875
ESHHKGHFIYKNVSE	CETP	246	P11597
DYLEVAKHFKPHGFS	ATF4	36	P18848
IQHYKQFRSHTPKFS	FAT4	4636	Q6V0I7
HFLHYSSVDKANPKE	AAR2	56	Q9Y312
ELLKYTHPQHRDFKD	ARHGEF4	436	Q9NR80
QLKDAHRSHPFIKEY	COPE	276	O14579
HRSHPFIKEYQAKEN	COPE	281	O14579
ARDHFGSKHPKYSDT	APPBP2	276	Q92624
TAEPDDSHALYAKKL	NPR2	671	P20594
YPLAHKVFEEKTQHL	DDX20	286	Q9UHI6
KLADDHKDPHYVQQA	DENND3	816	A2RUS2
KQYTIPCHTKAAHFD	CHD1	1236	O14646
VHPHKTYFTVAEKGS	CFAP44	191	Q96MT7
HQKRTPDFHDKYGNA	COX7B	26	P24311
DEGHNVSEKSKYHLY	DPP10	756	Q8N608
RHKKPVNYSQFDHSD	RAD51AP1	6	Q96B01
EEAHKLPVKHFTNPY	RASA1	601	P20936
TNHEFTYHKSKGDQP	RASA3	606	Q14644
TSFYLPKDAVKHLHV	RASSF1	206	Q9NS23
YLSYHSNTLKPHAKD	RASSF6	161	Q6ZTQ3
NKLKHYPSIHGDFSN	INTS9	371	Q9NV88
SAKKDNDFIYHEAVP	PTPN23	311	Q9H3S7
SVYKLHPSFKERFHA	GCK	411	P35557
YKNHKKTHSEERPFQ	PRDM5	391	Q9NQX1
SYEKIHLDFLKSDHP	PDGFRA	961	P16234
LDKVNNPDHSTYHDF	MAP4K3	286	Q8IVH8
SVKLLHPFHEQFSDY	MDN1	5431	Q9NU22
HKPKGIHEQELSYFA	KMT2C	4506	Q8NEZ4
FHEAAKLYKRSGHEN	IFT122	706	Q9HBG6
YVLKHPKEAFHSNFV	LDB1	141	Q86U70
PHKANAEEMTKYHSD	HDAC1	56	Q13547
HDEDPQAVTYAKVKH	LILRB4	351	Q8NHJ6
FQHLTHPYPSEEQKK	MEIS2	296	O14770
TKVYAALGNHDFHPK	SMPDL3B	126	Q92485
ALKLHQDHFTSPDEY	PCNX3	1646	Q9H6A9
KHYQFASGAFLHIKE	PDCD6IP	151	Q8WUM4
NHCRLSKAKEPHFEY	KIAA1586	96	Q9HCI6
AKHYKSASPQPAFHL	PCDH9	936	Q9HC56
DIDHTQYKFGHTKVF	MYH2	756	Q9UKX2
LPEDYKAQALAAFHH	FGD5	1206	Q6ZNL6
YDKAINRKTGVHFHP	NIPBL	2576	Q6KC79
SHVKHSPDFHDKYGN	COX7B2	26	Q8TF08
EVRESFHKLAKQYHP	DNAJC28	66	Q9NX36
FHKLAKQYHPDSGSN	DNAJC28	71	Q9NX36
KNGDFHYKQIPISDH	DUSP9	246	Q99956
QHLSGYHFKLKFDPE	PTGS2	336	P35354
DDPRSKHKFKIHTYS	PRKCB	96	P05771
YVHTKNFLHRDIKPD	CSNK1A1L	126	Q8N752
FKDIIHYDPTKQDHA	NOL8	941	Q76FK4
HYDPTKQDHATYERK	NOL8	946	Q76FK4
TVIHVKAHFDYDPSD	PALS1	346	Q8N3R9
DPSKAFHHESKENFA	HMMR	686	O75330
EDFKKSYSHSALLPH	DNAJC5G	31	Q8N7S2
AFALYHKALDLQKHD	CABIN1	36	Q9Y6J0
YHNRSPDFHEEIKVK	DOCK7	621	Q96N67
HHLYFNDKLEAPRKS	DOCK7	1021	Q96N67
DALHKNHKDVTDSFY	LIG4	51	P49917
KPPNSKLERFTYHHE	GCNT4	256	Q9P109
ALDHDPVENKIYFAH	EGF	516	P01133
LFFYKSHQDNHPLAS	FARP1	961	Q9Y4F1
NVYYHITSKHASPDK	CHAMP1	76	Q96JM3
VFHEESPKNNYKLFH	FUT10	146	Q6P4F1
SHLAAFYEDKKGVLH	DENND11	186	A4D1U4
SLVHHVKEQYFKSAA	BCLAF1	611	Q9NYF8
NSHPKFIHKDYQAEV	FAT3	1666	Q8TDW7
KDHLVTAYNHLFETK	FKBP3	56	Q00688
YHLDNHPEKQFSTDV	IFIT3	181	O14879
SKDEHFDKVTVLHYS	ANK3	2531	Q12955
DADQIESDKKHHYLP	ANK3	3261	Q12955
QAKSGKFNPHVHVEY	ASAP1	691	Q9ULH1
INALFAEAKHYHAKL	BLOC1S6	101	Q9UL45
KDRKYFHHNSDFHIP	FCGR3B	146	O75015
TKFHSFPNVYHELSK	LYPLAL1	201	Q5VWZ2
NKHYNHDLKFFTTPD	FGL2	346	Q14314
SKPHHDDINFYSERK	CCDC168	6996	Q8NDH2
PIQAKTFHHVYSGKD	DDX21	211	Q9NR30
PDIHHSNEEYFKKVE	FAM161A	86	Q3B820
KHPVSEYKAHFSLRN	COLGALT1	531	Q8NBJ5
FHHNSDFYIPKATLK	FCGR3A	151	P08637
PDKDEHLNKDFFRYH	CAPN9	426	O14815
SDYEDALPKHSFVNH	SDK1	2131	Q7Z5N4
HPAEQYVSKLKTFAD	COL6A6	381	A6NMZ7
VNFKELAEHHRSKYP	FAM120B	21	Q96EK7
YSHNLIALFEHAKKP	MAP4K5	576	Q9Y4K4
KKVELFHYQDGAFHT	PDIA5	106	Q14554
DKKHARHFSLDVHPY	PANX2	506	Q96RD6
FQHLSHPYPSEEQKK	MEIS3P1	181	A6NDR6
EPDSTEYIKVHHKTY	MRPS22	236	P82650
KFIFHSHRTPDAKYT	SKOR1	221	P84550
KKEYRDDPFHQSHLP	PHTF2	436	Q8N3S3
LDPKHTVYEDQLAKH	TRMT13	61	Q9NUP7
YKDAIHFYNKSLAEH	STIP1	316	P31948
EHSKKYPGFLLNNFH	TRPC4AP	716	Q8TEL6
TFLFQKPGDKYEHHS	POMT2	126	Q9UKY4
HTDDTINKKGFHIRY	TLL1	986	O43897
CKEPHKTFVYDLDSH	NCKAP5	461	O14513
SDPKSFAHCASVYKH	RHOT2	496	Q8IXI1
LHQKHAAFVTPDQKY	MYBL2	496	P10244
LSHYDSDIKEQKPEH	ARHGAP15	216	Q53QZ3
QHAKDFKEYHRSVTG	SMARCA4	481	P51532
VYNKDPAHAFNHTPK	KIAA1217	261	Q5T5P2
YHILENHKFTKESHA	SIX6	71	O95475
HYATLSFHKVKPQDP	SIGLEC8	446	Q9NYZ4
NPSHHFIDSSLYKDV	ST6GAL2	351	Q96JF0
DIDHTQYKFGHTKVF	MYH3	751	P11055
QGALYSLFPDHHVKK	RGN	131	Q15493
SLFPDHHVKKYFDQV	RGN	136	Q15493
QKFAEYTHKSPRVHS	SPG21	116	Q9NZD8
DHDISMFKAPAYTLH	ODF3L1	56	Q8IXM7
TDEKSKASHHIYPYS	SMARCC1	196	Q92922
NHDFLFHGSIYPKLK	OSBPL2	191	Q9H1P3
ENYDEHISNFHSKLK	CAMKMT	286	Q7Z624
HPKIKSFYFAAEHLD	CNKSR2	641	Q8WXI2
KFYNHPLHFVFNDTK	CNNM2	516	Q9H8M5
YNHPLHFVFNDTKLD	CNNM3	386	Q8NE01
KFHAQHEGESVSYAK	NCOA2	306	Q15596
HEKYKHPSHDYDISL	TMPRSS11E	266	Q9UL52
FDLTPYKTAEHHKDI	ZNF384	546	Q8TF68
FRNHETTHTGEKPYK	ZNF441	406	Q8N8Z8
LRKNFPHSFYKKSHA	ZNF846	151	Q147U1
LFQHQKTHTGEKPYE	ZNF573	401	Q86YE8
LYSISHEHSKDRKPF	ZNF365	101	Q70YC5
FNHVPAHDKKELSYR	RGS12	751	O14924
HPKFHYKQAHDSGTD	WDR70	366	Q9NW82
PKSHYRKHLFSESNQ	SYCP2L	496	Q5T4T6
HEQSHSDKLPFKCTY	ZNF521	136	Q96K83
HNSHDPSYFACLIKE	TBC1D1	106	Q86TI0
HHLQETSFTKEAYNK	nan	81	Q56UQ5
YSFQNHKTTHAGEKP	ZNF799	461	Q96GE5
RKDLVYTKANPTFHH	SPRED2	76	Q7Z698
HHKYQNLKCPELFSF	TRIM60	256	Q495X7
DLHKSELYKPEQTYH	SAXO2	91	Q658L1
AHKAVLAAASPYFHD	ZBTB9	61	Q96C00
SYPVHFKKEEASSLN	ZNF644	756	Q9H582
KDSYLKQLPHFTSEH	SNRNP200	1956	O75643
KYDSLSDHNSKFHPG	ZHX2	121	Q9Y6X8
HAKKHYEDAQVPLTN	USP3	56	Q9Y6I4
QCKSLEYQHLPAHKF	ZSWIM6	666	Q9HCJ5
QCEKSFYQKPHLTEH	ZNF25	206	P17030
YLLTEHFKTHTEEKP	ZNF121	241	P58317
FAYPSELKAHEAKHA	ZNF366	346	Q8N895
QPSREFASKAKDSHY	TOPORS	811	Q9NS56
FQTHERLHTGKKPYD	ZNF443	156	Q9Y2A4
FQNHKTTHTGEKPYE	ZNF443	491	Q9Y2A4
LFLHKALHTADKPYE	ZNF28	286	P17035
SFSVFHYKNPKLQHT	PLEKHG1	381	Q9ULL1
HEQIHSDKLPFKCTY	ZNF423	156	Q2M1K9
RGQSYSHEEPKFHHK	ZC3H12C	686	Q9C0D7
FTKHQRIHTDDKPYE	ZNF529	521	Q6P280
SNLSYHLEKNHPEEF	ZBED1	61	O96006
SEDHINRKYAFKAAH	PLEKHA5	226	Q9HAU0
HRDKALHFYTFPKDA	THAP11	16	Q96EK4
FLHTKEDTYENLHKV	TFR2	596	Q9UP52
EFLYDEVHPKQHAFK	TWF2	306	Q6IBS0
DFLYEEVHPKQHAHK	TWF1	306	Q12792
FNDKSSYNKHLKAHS	ZNF337	301	Q9Y3M9
SYNKHLKAHSGEKPF	ZNF337	306	Q9Y3M9
NFNAHKVIHTAEKPY	ZNF729	306	A6NN14
HKFSIHNYKVPTFCD	PRKCH	246	P24723
VKKVPNSEEYHSHLF	NAA25	106	Q14CX7
DKKHHYNPLESASFR	NEBL	241	O76041
LKQDSSPDHEKSYHY	NEUROD2	311	Q15784